Literature DB >> 26179030

Management of ischemic stroke in Central and Eastern Europe.

Hrvoje Budincevic1,2, Cristina Tiu3, Daniel Bereczki4, Janika Kõrv5, Alexander Tsiskaridze6, Kurt Niederkorn7, Anna Czlonkowska8, Vida Demarin9.   

Abstract

Stroke is one of the leading causes of disability in Europe. Central and Eastern European countries have the highest incidence and mortality rates through Europe. The improvements in stroke prevention and treatment in Central and Eastern European countries did not completely reach the quality parameters present in Western European countries. We present features of current management of stroke in Central and Eastern European countries.
© 2015 World Stroke Organization.

Entities:  

Keywords:  Central Europe; Eastern Europe; stroke epidemiology; stroke incidence; stroke units; thrombolysis

Mesh:

Year:  2015        PMID: 26179030     DOI: 10.1111/ijs.12575

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  4 in total

1.  The adaption and evaluation of a Latvian version of the National Institutes of Health Stroke Scale.

Authors:  Kristaps Jurjāns; Iļja Noviks; Diāna Volčeka; Linda Zandersone; Kristīne Meilerte; Evija Miglāne; Ainars Stepens; Andrejs Millers
Journal:  J Int Med Res       Date:  2016-11-10       Impact factor: 1.671

2.  Adaption and validation of the Mississippi Aphasia Screening Test to Estonian speakers with aphasia.

Authors:  Aaro Nursi; Marika Padrik; Liisa Nursi; Maarja Pähkel; Liis Virkunen; Anne Küttim-Rips; Pille Taba
Journal:  Brain Behav       Date:  2018-12-19       Impact factor: 2.708

3.  Financial Burden of Stroke Reflected in a Pilot Center for the Implementation of Thrombolysis.

Authors:  Diana Uivarosan; Simona Bungau; Delia Mirela Tit; Corina Moisa; Ovidiu Fratila; Marius Rus; Ovidiu Gabriel Bratu; Camelia C Diaconu; Carmen Pantis
Journal:  Medicina (Kaunas)       Date:  2020-01-28       Impact factor: 2.430

4.  Ischemic stroke - the challenge continues.

Authors:  Vida Demarin; Hrvoje Budinčević
Journal:  Croat Med J       Date:  2016-06-30       Impact factor: 1.351

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.